You have 9 free searches left this month | for more free features.

js001

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, JS001)

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • Beijing, Beijing, China
  • +2 more
Apr 2, 2022

Solid Tumor, Tumors, Malignant Tumor Trial in Changchun (ES102, JS001)

Recruiting
  • Solid Tumor
  • +2 more
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Oct 28, 2021

Esophageal Small Cell Carcinoma Trial in Guangzhou (JS001, nab-paclitaxel, Cisplatin)

Recruiting
  • Esophageal Small Cell Carcinoma
  • JS001
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 27, 2021

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (postoperative radiotherapy, JS001)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • postoperative radiotherapy
  • JS001
  • Shanghai, China
    Guopei Zhu
Apr 12, 2021

Triple-Negative Breast Cancer Trial in China (JS001, Nab-Paclitaxel, Placebo)

Recruiting
  • Triple-Negative Breast Cancer
  • JS001
  • +2 more
  • Beijing, Beijing, China
  • +55 more
Sep 13, 2022

Colorectal Cancer Trial in Guangzhou (JS001, regorafenib tablet)

Unknown status
  • Colorectal Cancer
  • JS001
  • regorafenib tablet
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 11, 2020

Colorectal Cancer Trial in Shanghai (JS001)

Unknown status
  • Colorectal Cancer
  • JS001
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Oct 5, 2019

Gastric Cancer, Locally Advanced Solid Tumor Trial in Guangzhou (JS001, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Locally Advanced Solid Tumor
  • JS001
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 5, 2020

Efficacy and Safety Trial in Guangzhou (JS001, Pemetrexed, Carboplatin)

Active, not recruiting
  • Efficacy and Safety
  • JS001
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 12, 2019